Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort

Burosumab effectively increased serum phosphate levels and improved clinical outcomes in a real-world setting, particularly in patients with more substantial increases in serum phosphate levels. Baseline serum phosphate, PTH, and FGF23 levels predicted response, helping tailor treatment strategies and improve long-term patient management.

Authors

Institutions

Publication Details

Journal
Journal of Endocrinological Investigation
Published
2025-05-05
DOI
https://doi.org/10.1007/s40618-025-02596-3
Citations
2
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort

Maria Michela D’Alessandro, Elena Campello, Michele Cannito, Paolo Simioni et al.
2 citations
Journal of Endocrinological Investigation
Parathyroid Disorders and Treatments
2.86
article

Predictors of response to burosumab in adults with X-linked hypophosphatemia: real-world data from an Italian cohort

Maria Michela D’Alessandro, Elena Campello, Michele Cannito, Paolo Simioni, Marta Zampogna, Marco Onofrio Torres, Gaetana Cerbone, Maria Fusaro, Gemma Marcucci, Francesca Guidolin, Giuseppe Vezzoli, Maria Luisa Brandi, Valentina Camozzi, Gaetano Paride Arcidiacono, Sandro Giannini, Mor Peleg Falb, Corrado Vitale, Alberta Cecchinato, Cristina Eller-Vainicher, Giovanni Tripepi, Martina Zaninotto, Antonio Aversa, Giuseppe Girasole, Mario Plebani, Stefania Sella, Martin Diogo
article en
2 citations

Abstract

Burosumab effectively increased serum phosphate levels and improved clinical outcomes in a real-world setting, particularly in patients with more substantial increases in serum phosphate levels. Baseline serum phosphate, PTH, and FGF23 levels predicted response, helping tailor treatment strategies and improve long-term patient management.

Journal of Endocrinological InvestigationVol. 48(8)
University of Padua (IT), Vita-Salute San Raffaele University (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Magna Graecia University (IT), Istituto di Fisiologia Clinica (IT), Azienda Ospedaliera S.Giuseppe Moscati (IT), Fondazione Europea Ricerca Biomedica (IT), A. O. Ordine Mauriziano di Torino (IT), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), National Research Council (IT), Villa Torri Hospital (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT), University of Florence (IT)
Università degli Studi di Padova
Openalex Percentile: Top 10%
Parathyroid Disorders and Treatments
2.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.